HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 14.37
-0.07 (-0.48%)
Sep 10, 2026, 11:59 AM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 12.53 billion as of September 9, 2026. Its market cap has decreased by -12.94% in one year.
Market Cap
12.53B
Enterprise Value
10.41B
Revenue
1.40B
Ranking
n/a
PE Ratio
17.97
Stock Price
14.37
ChartMarket Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 12.53B, an increase of 48.05%. That is a compound annual growth rate of 7.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 12.53B | 23.24% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metis TechBio | 18.23B |
| Duality Biotherapeutics | 16.28B |
| Ascentage Pharma Group International | 12.35B |
| Nanjing Leads Biolabs | 12.14B |
| Everest Medicines | 11.00B |
| Ascletis Pharma | 10.66B |
| GenFleet Therapeutics (Shanghai) | 10.33B |
| Suzhou Ribo Life Science | 9.70B |